Tuesday, 29 September 2026Updated 8m ago
← Top stories
Market move▲ Bullish for Indian equities

Nifty Pharma defies market slump as select drugs get US tariff exemption

1 source · first seen 09:39 29 Sept · updated 09:39 29 Sept

The brief

Written from 1 report · check the source before you trade
  • Qualifying speciality medicines from India will be eligible for zero US duty
  • The exemption provides some relief to Indian drugmakers with US exposure
  • Zero-duty access could support Indian pharma exporters with qualifying speciality medicines

Tags on this story

Pick a tag to see all its stories
US tariffs17 todayPharma and healthcare35 todayTrade and tariffs56 todayUS drug pricing3 todayNifty and Sensex109 today

Linked by the tag US drug pricing

4 stories this week
  1. 28 SeptPharma sector eyes 10% growth in FY27 as domestic market offsets US slowdown1 source
  2. 26 SeptOncologist calls for five-year plan to widen access to precision cancer carePolicy · 2 sources · The proposed agenda would expand access to genomic testing and targeted cancer therapies for lower-income patients
All US drug pricing stories →
Part of a developing story3 updates over 3 days

US tariffs and exemptions affecting India

A proposed US law could allow tariffs of up to 100% on the largest buyers of Russian oil, potentially affecting India. A report said the US exempted India and 19 other nations from 100% tariffs on certain speciality drugs.

Tuesday, 29 September

  1. You are here
    Nifty Pharma defies market slump as select drugs get US tariff exemption

Monday, 28 September

  1. 2 sources
    US exempts speciality drugs from 100% tariffs for India and 19 other nations

Sunday, 27 September

  1. US trade deal could shield India from 100% tariff under Russian sanctions law: Sources

Follow the full storyline →

Read the reports

1 report · earliest 09:39
Business StandardNifty Pharma defies market slump as select drugs get US tariff exemption09:39